To prevent selection of random genetic alterations in ASCIZ/ATMIN knockout cell lines, we adopted a doxycycline-inducible CRISPR/Cas9 approach that has recently been optimized for human Burkitt lymphoma cell lines [27]. Here, ATMIN is linked to Burkitt lymphoma.